Serum lipid levels and I-PSS or Qol are not linked in prostatic hyperplasia

Key points
- Serum lipid levels and International Prostate Symptom Score or Quality of Life Score are not linked in prostatic hyperplasia.
- According to recent research from Turkey, "The relationship between serum lipid levels and measures of benign prostatic hyperplasia was investigated.
- "Body mass index was calculated with the formula of weight (kg)/surface area (m(2)) respectively.
- Investigators found "no correlation for serum lipid levels with either mean I-PSS and QoL scores.
Serum lipid levels and International Prostate Symptom Score or Quality of Life Score are not linked in prostatic hyperplasia.
According to recent research from Turkey, "The relationship between serum lipid levels and measures of benign prostatic hyperplasia was investigated. The study was community based. All the participants had undergone a urological investigation which included International Prostate Symptom Score (I-PSS) and Quality of Life Score (QoL), serum lipid concentrations and determination of prostate volume with transrectal ultrasonography."
"Body mass index was calculated with the formula of weight (kg)/surface area (m(2)) respectively. Men were considered obese if their body mass index was over 25 kg/m(2). BPH was defined by prostate volume greater than 20 ml and I-PSS greater than seven. Comparisons of serum lipid levels between men with BPH and without BPH were done," wrote M. Lekili and associates at Celal Bayar University.
Investigators found "no correlation for serum lipid levels with either mean I-PSS and QoL scores. However, triglyceride and cholesterol levels were the lowest in severe symptomatic men than men with low symptoms. Using clinical definition of BPH that prostate volume was greater than 20 ml and I-PSS was greater than seven, men with BPH had not significantly different serum lipid levels from men without BPH."
The researchers concluded, "Our population-based data reflect that there was no relationship between serum lipid levels and certain physiological measures of lower urinary tract symptoms and clinical benign prostatic hyperplasia."
Lekili and colleagues published their study in World Journal of Urology (Serum lipid levels in benign prostatic hyperplasia. World J Urol, 2006;24(2):210-213).
For additional information, contact M. Lekili, Celal Bayar University, Faculty Medical, Dept. of Urology, TR-45010 Manisa, Turkey.
Publisher contact information for the World Journal of Urology is: Springer, 233 Spring Street, New York, NY 10013, USA.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsBiomarker linked to aggressive breast cancers, poor outcomes in African-Americans
Among African-American women with breast cancer, increased levels of the protein HSET were associated with worse breast cancer outcomes, according to results presented here at the Sixth AACR Conference on the Science of…
9 December 2013
NewsBreast Cancer Linked to High-cholesterol Diets Recent Research Shows
Cholesterol has been shown to contain a bi-product that when consumed in high quantities in diets may be linked to breast cancer. According to a U.S. study the effects may be similar to the way estrogen increases the…
1 December 2013
NewsHigher than normal levels of Vitamin B12 may indicate cancer risk
Vitamin B12 (cobalamin [Cbl]) is essential for maintaining healthy bodily function but higher than normal levels (reference range 200-600 pmol/L) may indicate that a patient is at risk of developing certain cancers,…





